| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/164_2017_32 |
| P698 | PubMed publication ID | 28510066 |
| P50 | author | Louis Gendron | Q42564121 |
| P2093 | author name string | Khaled Abdallah | |
| P2860 | cites work | Structure of the human κ-opioid receptor in complex with JDTic | Q24308048 |
| Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor | Q24311708 | ||
| Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment | Q24318653 | ||
| Identification of a novel family of G protein-coupled receptor associated sorting proteins | Q24336955 | ||
| Dynorphin-(1-13), an extraordinarily potent opioid peptide | Q24561638 | ||
| Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands | Q24561925 | ||
| The evolution of vertebrate opioid receptors | Q24627645 | ||
| Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain | Q27317157 | ||
| Crystal structure of the µ-opioid receptor bound to a morphinan antagonist | Q27678133 | ||
| Structure of the δ-opioid receptor bound to naltrindole | Q27679153 | ||
| Molecular control of δ-opioid receptor signalling | Q27681274 | ||
| Cloning of a delta opioid receptor by functional expression | Q28213132 | ||
| Modulation of postendocytic sorting of G protein-coupled receptors | Q28216085 | ||
| Chromosomal localization of the delta opioid receptor gene to human 1p34.3-p36.1 and mouse 4D bands by in situ hybridization | Q28244218 | ||
| A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80 | Q28255208 | ||
| A library of 7TM receptor C-terminal tails. Interactions with the proposed post-endocytic sorting proteins ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled ... | Q28285048 | ||
| Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications | Q28287619 | ||
| Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859) | Q28293705 | ||
| Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study | Q28294827 | ||
| Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors | Q28366271 | ||
| Cloning and pharmacological characterization of a rat kappa opioid receptor | Q28378330 | ||
| Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism | Q28488120 | ||
| Primary afferent tachykinins are required to experience moderate to intense pain | Q28506575 | ||
| Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses | Q28510086 | ||
| Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors | Q28582515 | ||
| The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization | Q30800519 | ||
| Opioids in pain management | Q33678609 | ||
| Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn | Q33811673 | ||
| Nerve growth factor-regulated emergence of functional delta-opioid receptors | Q33832271 | ||
| Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons | Q33907117 | ||
| Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. | Q34059144 | ||
| Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal | Q34104454 | ||
| Peripheral G protein-coupled inwardly rectifying potassium channels are involved in δ-opioid receptor-mediated anti-hyperalgesia in rat masseter muscle. | Q34127330 | ||
| Identification of two related pentapeptides from the brain with potent opiate agonist activity | Q34134593 | ||
| Structure and regulation of opioid receptors | Q34136307 | ||
| Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice | Q34155247 | ||
| Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series | Q34244966 | ||
| Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity | Q34354902 | ||
| beta-endorphin is a potent analgesic agent | Q34394408 | ||
| Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. | Q34424009 | ||
| Peripheral opioid analgesia. | Q34442053 | ||
| Acute Migraine Treatment in Adults | Q34471863 | ||
| Exploring the opioid system by gene knockout | Q34641459 | ||
| Excessive acute migraine medication use and migraine progression | Q34887527 | ||
| Peripheral mechanisms of opioid analgesia | Q34926296 | ||
| Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities | Q34939624 | ||
| Recent advances on the δ opioid receptor: from trafficking to function | Q34939664 | ||
| Dissociation of the opioid receptor mechanisms that control mechanical and heat pain | Q34986633 | ||
| Origin of pain in migraine: evidence for peripheral sensitisation | Q34987743 | ||
| Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking | Q34989880 | ||
| Postnatal development of delta-opioid receptor subtypes in mice | Q35025861 | ||
| Historical review: Opioid receptors | Q35111648 | ||
| Activation of peripheral delta-opioid receptors leads to anti-hyperalgesic responses in the masseter muscle of male and female rats | Q35165222 | ||
| Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures | Q35243440 | ||
| Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart | Q35286353 | ||
| Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain | Q35327954 | ||
| The delta opioid receptor: an evolving target for the treatment of brain disorders | Q35400738 | ||
| Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles | Q35469264 | ||
| Inflammatory pain is enhanced in delta opioid receptor-knockout mice | Q35653788 | ||
| Reward processing by the opioid system in the brain. | Q35786247 | ||
| Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR | Q36004099 | ||
| Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia | Q36372689 | ||
| Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist | Q36382976 | ||
| Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches | Q36438816 | ||
| Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance | Q36470261 | ||
| Delta-opioid receptor agonist SNC80 induces peripheral antinociception via activation of ATP-sensitive K+ channels | Q44348602 | ||
| Delta-opioid receptor-immunoreactive neurons in the rat cranial sensory ganglia | Q44348828 | ||
| Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia | Q44349361 | ||
| Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia | Q44350199 | ||
| The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions | Q44350702 | ||
| Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia | Q44350955 | ||
| Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice | Q44351559 | ||
| Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. | Q44351651 | ||
| Neuropathic pain is enhanced in delta-opioid receptor knockout mice | Q44351896 | ||
| The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice. | Q45918209 | ||
| The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine | Q48283682 | ||
| Enkephalinergic afferents of the centromedial amygdala in the rat. | Q48574704 | ||
| Antinociceptive potencies of β-casomorphin analogs as compared to their affinities towards μ and δ opiate receptor sites in brain and periphery | Q48906923 | ||
| Microinjection of opiates into the periaqueductal gray matter attenuates neuropathic pain symptoms in rats. | Q51397850 | ||
| Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. | Q54575252 | ||
| Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. | Q55063215 | ||
| mu opiate receptor: cDNA cloning and expression | Q36641338 | ||
| Opioid receptors: distinct roles in mood disorders | Q36675341 | ||
| Cloning and expression of a cDNA for the rat kappa-opioid receptor | Q36741807 | ||
| Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels | Q36753640 | ||
| Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents | Q37056129 | ||
| Molecular Pharmacology of δ-Opioid Receptors | Q37062556 | ||
| Delta opioid receptors in brain function and diseases | Q37179419 | ||
| GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity | Q37239111 | ||
| Opioid receptors: from binding sites to visible molecules in vivo | Q37249017 | ||
| Effects of intrathecal SNC80, a delta receptor ligand, on nociceptive threshold and dorsal horn substance p release | Q37252030 | ||
| Spinal activation of delta opioid receptors alleviates cancer-related bone pain | Q37360319 | ||
| Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli | Q37360341 | ||
| Characterization of a novel model of chronic migraine | Q37576753 | ||
| Sorting of neuropeptides and neuropeptide receptors into secretory pathways | Q37620744 | ||
| Transcriptional and epigenetic regulation of opioid receptor genes: present and future | Q37792084 | ||
| Extending pharmacological spectrum of opioids beyond analgesia: multifunctional aspects in different pathophysiological states | Q37826255 | ||
| Cortical spreading depression and migraine | Q38138398 | ||
| Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors | Q38344737 | ||
| Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide. | Q38350445 | ||
| Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain | Q38395503 | ||
| Eluxadoline: First Global Approval | Q38543345 | ||
| What can we learn about rheumatoid arthritis from animal models? | Q38760986 | ||
| Delta-opioid receptors as targets for migraine therapy | Q38792542 | ||
| Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment | Q38908375 | ||
| Analgesia targeting IB4-positive neurons in cancer-induced mechanical hypersensitivity | Q39249576 | ||
| Selective delta opioid receptor agonists for inflammatory and neuropathic pain | Q39419113 | ||
| The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic pain | Q39546846 | ||
| Tuned-Affinity Bivalent Ligands for the Characterization of Opioid Receptor Heteromers | Q39738929 | ||
| Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance. | Q39871479 | ||
| Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5. | Q39959986 | ||
| A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes | Q40446034 | ||
| A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers | Q40551758 | ||
| Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more | Q40857019 | ||
| Opioid receptor types and subtypes: the delta receptor as a model. | Q41048199 | ||
| Type-specific sorting of G protein-coupled receptors after endocytosis | Q41728938 | ||
| Increased abundance of opioid receptor heteromers after chronic morphine administration | Q42081407 | ||
| Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn | Q42177229 | ||
| Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. | Q42463227 | ||
| Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia | Q42476246 | ||
| Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d). | Q42717480 | ||
| Endogenous opioids: overview and current issues | Q43070748 | ||
| Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands | Q43120295 | ||
| Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation | Q43263736 | ||
| Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747). | Q43289095 | ||
| Anatomical evidence for presynaptic modulation by the delta opioid receptor in the ventrolateral periaqueductal gray of the rat. | Q43514532 | ||
| The role of delta-opioid receptor subtypes in neuropathic pain | Q43540650 | ||
| Parallel synthesis and biological activity of a new class of high affinity and selective delta-opioid ligand | Q43737770 | ||
| Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats | Q44174860 | ||
| Opioid receptor-induced GTPgamma35S binding during mouse development | Q44254666 | ||
| Cancer-related bone pain is attenuated by a systemically available delta-opioid receptor agonist | Q44329855 | ||
| Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice | Q44330126 | ||
| Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice | Q44330314 | ||
| Chronic morphine administration results in tolerance to delta opioid receptor-mediated antinociception | Q44330555 | ||
| Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices | Q44330617 | ||
| Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain | Q44331988 | ||
| Electron microscopic localization of photoaffinity-labelled delta opioid receptors in the neostriatum of the rat | Q44332255 | ||
| Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia | Q44333074 | ||
| Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain | Q44333270 | ||
| Equal proportions of small and large DRG neurons express opioid receptor mRNAs | Q44334243 | ||
| Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms | Q44335160 | ||
| Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain | Q44335378 | ||
| Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla | Q44336043 | ||
| Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study | Q44336066 | ||
| Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization | Q44337234 | ||
| Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA. | Q44338426 | ||
| Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. | Q44338675 | ||
| Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control | Q44340167 | ||
| Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain | Q44341214 | ||
| Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. | Q44342444 | ||
| Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia | Q44342783 | ||
| Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB | Q44343055 | ||
| Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat. | Q44344453 | ||
| Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice | Q44345360 | ||
| The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice | Q44345943 | ||
| Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand | Q44347450 | ||
| Comparison between delta-opioid receptor functional response and autoradiographic labeling in rat brain and spinal cord | Q44347541 | ||
| Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord | Q44347864 | ||
| Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles | Q44347921 | ||
| Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice | Q44348234 | ||
| Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. | Q44348492 | ||
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 147-177 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Handbook of experimental pharmacology | Q26841924 |
| P1476 | title | The Delta Opioid Receptor in Pain Control | |
| P478 | volume | 247 |
| Q95660672 | Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies |
| Q43075742 | Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics. |
| Q51744085 | Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1. |
| Q90061419 | From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception |
Search more.